Swiss Biotech Report 2005

More documents

Recommendations

Info

02 ONE NATION WITH REGIONAL CLUSTERS D GREATER ZURICH AREA BIO VALLEY BASLE ZURICH D LAUSANNE BELLINZONA D GENEVA BIO ALPS LUGANO BIO POLO Switzerland lies at the heart of one of the world’s leading biotechnology regions, which also includes the neighbouring areas of France, Germany and Italy. The Swiss biotech industry is among the largest and most diversified in Europe. D
INDEX 03 INCREASING NUMBER OF PATENTS / by Heinz Müller, Swiss Federal Institute of Intellectual Property . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 04 PREFACE / by Joseph Deiss, Minister for Economic Affairs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 05 A PRIME BUSINESS LOCATION FOR LIFE SCIENCE COMPANIES / by Location Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 06 INDUSTRY STATEMENTS / Interviews with Ernesto Bertarelli (CEO Serono), Markus Moser (CEO Prionics), Jean-Paul Clozel (CEO Actelion) . . . . 08 NEW TREATMENTS FOR CNS DISORDERS / Company portrait: Addex Pharmaceuticals, Geneva . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11 WHAT KEEPS SWISS BIOTECHNOLOGY GOING / by the CTI, the national Innovation Promotion Agency . . . . . . . . . . . . . . . . . . . . . . . . . . . .12 BASIC RESEARCH: «SWITZERLAND IS STILL AT THE TOP» / Interview with Nobel Prize winner Kurt Wüthrich . . . . . . . . . . . . . . . . . . . . 14 BRIDGING THE GAP BETWEEN RESEARCH AND INNOVATION / Swiss Biotechnet: Linking research and industry . . . . . . . . . . . . . . . 16 THE MOTOR OF ECONOMIC GROWTH IS IN SHORT SUPPLY Interview with Henri B. Meier, Chairman of the Board of HBM BioVentures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 THE SWISS BIOTECH INDUSTRY, A SUCCESS STORY / by Ernst & Young . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 FINDING ANTIBODIES IN AN EASIER WAY / Company portrait: 4-Antibody, Basle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 SWX – THE LIFE SCIENCE STOCK EXCHANGE / by SWX Swiss Exchange . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 «THE BIOTECH INDUSTRY IS SET TO GROW» / Round-table discussion with financial experts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 FAST TRACK TO NEW DRUGS / Company portrait: Oncore Therapeutics, Lugano . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 ONE VOICE FOR SUCCESS / Portrait Swiss Biotech Association – Interview with Domenico Alexakis, Executive Director . . . . . . . . . . . . . . . . . . . . 27 A NEW GENERATION OF IMPLANTS / Company portrait: Symetis, Zurich . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 MILESTONES IN MODERN BIOTECHNOLOGY / Timeline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 APPENDIX / Facts and Figures on Swiss biotechnology by Ernst & Young . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Page 4 and 5: 04 INCREASING NUMBER OF PATENTS 70
Page 6 and 7: 06 A PRIME BUSINESS LOCATION FOR...
Page 8 and 9: 08 INDUSTRY STATEMENTS ERNESTO BERT
Page 10 and 11: 10 Markus Moser: This process is a
Page 12 and 13: 12 WHAT KEEPS SWISS... THE INNOVATI
Page 14 and 15: 14 «SWITZERLAND IS STILL... BASIC
Page 16 and 17: 16 BRIDGING THE GAP BETWEEN... NETW
Page 18 and 19: 18 THE MOTOR OF ECONOMIC... HENRI B
Page 20 and 21: 20 THE SWISS BIOTECH INDUSTRY... IN
Page 22 and 23: 22 FINDING ANTIBODIES IN A EASIER W
Page 24 and 25: 24 «THE BIOTECH INDUSTRY... ROUNDT
Page 26 and 27: 26 FAST TRACK TO NEW DRUGS Dr Bo Ni
Page 28 and 29: 28 DOMENICO ALEXAKIS The Executive
Page 30 and 31: 30 MILESTONES IN... marked in red a
Page 32 and 33: 32 APPENDIX: FACTS AND FIGURES Many
Page 34 and 35: 34 BASLE ZURICH NUMBER OF BIOTECH C
Page 36: IMPRESSUM Steering Committee: Jürg

Swiss Biotech Report 2005

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?